X0206 3 2022-06-27 0 0001581760 Life360, Inc. 360.AX 0001932498 Hulls Chris C/O LIFE360, INC. 539 BRYANT STREET, SUITE 402 SAN FRANCISCO CA 94107 1 1 0 0 Chief Executive Officer Common Stock 3031429 D Common Stock 29960 I Held by ICCA Labs, LLC Stock Option (right to buy) 2.15 2027-10-24 Common Stock 208987 D Stock Option (right to buy) 2.53 2028-07-16 Common Stock 1269386 D Stock Option (right to buy) 9.55 2028-10-30 Common Stock 10 D Stock Option (right to buy) 7.28 2030-07-30 Common Stock 230000 D Stock Option (right to buy) 13.35 2031-02-01 Common Stock 100000 D Stock Option (right to buy) 8.19 2032-05-20 Common Stock 204573 D Includes 1,686,552 shares of the Issuer's common stock underlying 5,059,656 Chess Depositary Interests ("CDIs"). The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Also includes 103,596 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Represents shares of the Issuer's common stock underlying 89,880 CDIs. The Reporting Person is a member of ICCA Labs, LLC, an entity that holds an aggregate of 133,408 shares of the Issuer's common stock underlying 400,224 CDIs. The number of shares reported herein by the Reporting Person represents his proportionate ownership interest in ICCA Labs, LLC. The stock option is fully vested and exercisable. The stock option vests and becomes exercisable as to 1/48th of the total number of shares in equal monthly installments beginning on August 16, 2018, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. The stock option vests and becomes exercisable as to 1/48th of the total number of shares in equal monthly installments beginning on August 30, 2020, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. The stock option vests and becomes exercisable as to 1/48th of the total number of shares in equal monthly installments beginning on March 1, 2021, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. The stock option vests and becomes exercisable as to 1/48th of the total number of shares in equal monthly installments beginning on February 1, 2022, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. /s/ Daniel Menudier, as Attorney-in-Fact 2022-06-27